Crown Reserve Acquisition Corp. I (NASDAQ:CRAC) & Uxin (NASDAQ:UXIN) Financial Contrast

Crown Reserve Acquisition Corp. I (NASDAQ:CRAC) and Uxin (NASDAQ:UXIN) are both small-cap consumer discretionary companies, but which is the superior investment? We will contrast the two companies based on the strength of their valuation, analyst recommendations, risk, profitability, earnings, institutional ownership and dividends.

Insider & Institutional Ownership

22.4% of Uxin shares are owned by institutional investors. 62.9% of Uxin shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

Profitability

This table compares Crown Reserve Acquisition Corp. I and Uxin’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Crown Reserve Acquisition Corp. I	N/A	N/A	N/A
Uxin	-8.46%	N/A	-11.60%

Analyst Recommendations

This is a summary of current ratings and price targets for Crown Reserve Acquisition Corp. I and Uxin, as provided by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Crown Reserve Acquisition Corp. I	1	0	0	0	1.00
Uxin	1	0	1	0	2.00

Uxin has a consensus price target of $4.50, indicating a potential upside of 291.30%. Given Uxin’s stronger consensus rating and higher probable upside, analysts clearly believe Uxin is more favorable than Crown Reserve Acquisition Corp. I.

Valuation & Earnings

This table compares Crown Reserve Acquisition Corp. I and Uxin”s revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Crown Reserve Acquisition Corp. I	N/A	N/A	N/A	N/A	N/A
Uxin	$463.27 million	0.54	-$39.69 million	($0.21)	-5.48

Crown Reserve Acquisition Corp. I has higher earnings, but lower revenue than Uxin.

Summary

Uxin beats Crown Reserve Acquisition Corp. I on 6 of the 8 factors compared between the two stocks.

About Crown Reserve Acquisition Corp. I

We are a blank check company incorporated on April 29, 2025 as a Cayman Islands exempted company for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses, which we refer to throughout this prospectus as our initial business combination. We have generated no revenues to date and we do not expect that we will generate operating revenues at the earliest until we consummate our initial business combination. We have not selected any specific business combination target and we have not, nor has anyone on our behalf, engaged in any substantive discussions, directly or indirectly, with any business combination target with respect to an initial business combination with us. Crown Reserve Acquisition Corp. I intends to identify and acquire a business within an industry or sector that complements the experience of our management team and can benefit from our operational expertise. We will have a generalist approach to industry sectors, but with particular emphasis on industries where we have core competencies and experiences, such as pharma, medical technology and medical equipment, and healthcare IT industries. However, we may pursue an initial business combination opportunity in any industry or sector (subject to certain limitations described in this prospectus). We are a Cayman Islands exempted company incorporated on April 29, 2025. Our registered offices are located in Grand Cayman, Cayman Islands.

About Uxin

Uxin Limited, an investment holding company, engages in the retail sale of vehicles in China. The company operates an e-commerce platform for buying and selling used cars. It also offers used-car acquisition, inspection, reconditioning, warehousing, pre-sales and after-sales, and various car-related value-added products and services, as well as warranty and repair, delivery, and title transfers and vehicle registration services. Uxin Limited was incorporated in 2011 and is headquartered in Beijing, China.